Alfred E. Mann established the Alfred Mann Institute for Biomedical Development at Technion-Israel Institute of Technology AMIT is, focused on enabling commercialization of innovative biomedical technologies that improve human health.

University
Artificial Intelligence, Natural Language Processing, Speech Recognition
B2B, B2B2C, B2C, B2G
Software

Investment Portfolio

Active
2012
25

Investment Round History

August 4, 2020
$10,000,000
Series A
May 31, 2017
$2,000,000
Seed

Co-Investors

News

Register Pro to view more

Pro

$25 per month

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database

Select a Table to Export